UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Mathematical models to define growth patterns in indigenous horses of India

Indian journal of animal sciences, 2024-04, Vol.94 (4), p.386-392

2024

Volltextzugriff (PDF)

Phenotypic trend, breeding value and heritability of biometric traits in Marwari horses

Indian journal of animal sciences, 2021-09, Vol.91 (6)

2021

Volltextzugriff (PDF)

Ameliorative Effect of Ascorbic Acid and Glutathione in Combating the Cryoinjuries During Cryopreservation of Exotic Jack Semen

Journal of equine veterinary science, 2019-10, Vol.81, p.102796-102796, Article 102796

2019

Volltextzugriff (PDF)

Determination of genetic variability at αs1-casein gene in Indian dromedary

Indian journal of animal sciences, 2021-12, Vol.90 (12), p.1617-1621

2021

Volltextzugriff (PDF)

Genetic and demographic bottleneck analysis of Indian camel breeds by microsatellite markers

Tropical animal health and production, 2014-12, Vol.46 (8), p.1397-1406

Mehta, Sharat Chandra

2014

Volltextzugriff (PDF)

Freezability and Fertility Rates of Stallion Semen Supplemented With Trehalose in Lactose Extender

Journal of equine veterinary science, 2023-07, Vol.126, p.104293-104293, Article 104293

2023

Volltextzugriff (PDF)

Camelpox: A brief review on its epidemiology, current status and challenges

Acta tropica, 2016-06, Vol.158, p.32-38

2016

Volltextzugriff (PDF)

Molecular characterization of Camelpox virus isolates from Bikaner, India: Evidence of its endemicity

Acta tropica, 2017-07, Vol.171, p.1-5

2017

Volltextzugriff (PDF)

A prospective pilot study of a novel alemtuzumab target concentration intervention strategy

Bone marrow transplantation (Basingstoke), 2021-12, Vol.56 (12), p.3029-3031

2021

Volltextzugriff (PDF)

CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study

Bone marrow transplantation (Basingstoke), 2020-08, Vol.55 (8), p.1552-1559

2020

Volltextzugriff (PDF)

Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults

Transplantation, 2022-02, Vol.106 (2), p.412

2022

Volltextzugriff (PDF)

Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation

Clinical pharmacokinetics, 2018-05, Vol.57 (5), p.625-636

2018

Volltextzugriff (PDF)

Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series

British journal of haematology, 2021-09, Vol.194 (5), p.e84-e89

2021

Volltextzugriff (PDF)

Test‐dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non‐malignant disorders

British journal of clinical pharmacology, 2022-01, Vol.88 (1), p.115-127

2022

Volltextzugriff (PDF)

Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study

Journal of antimicrobial chemotherapy, 2018-06, Vol.73 (6), p.1651-1658

2018

Volltextzugriff (PDF)

Paperspray Ionization Mass Spectrometry as a Tool for Predicting Real-Time Optimized Dosing of the Chemotherapeutic Drug Melphalan

The journal of applied laboratory medicine, 2021-04, Vol.6 (3), p.625-636

2021

Volltextzugriff (PDF)

Daratumumab Is Safe and Effective for the Treatment of Refractory Autoimmunity in Children

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S459-S460

2021

Volltextzugriff (PDF)

Ruxolitinib for the Treatment of Chronic GVHD in Children and Young Adults

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S257-S258

2021

Volltextzugriff (PDF)

Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen

Biology of blood and marrow transplantation, 2015-08, Vol.21 (8), p.1460-1470

2015

Volltextzugriff (PDF)

Pretransplant Absolute Lymphocyte Counts Impact the Pharmacokinetics of Alemtuzumab

Biology of blood and marrow transplantation, 2017-04, Vol.23 (4), p.635-641

2017

Volltextzugriff (PDF)

An Intermediate Alemtuzumab Schedule Reduces the Incidence of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis

Biology of blood and marrow transplantation, 2013-11, Vol.19 (11), p.1625-1631

2013

Volltextzugriff (PDF)

Alemtuzumab Precision Dosing in Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S150-S150

2020

Volltextzugriff (PDF)

A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2016-12, Vol.22 (12), p.2220-2225

2016

Volltextzugriff (PDF)

Intravenous Posaconazole is Safe and Effective in Pediatric HSCT Patients

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S166-S166

2017

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Hematology, Oncology And Palliative Medicine
(18)
Humans
(8)
Hematology
(7)
Immunology
(7)
Transplantation
(7)
Child
(6)
Female
(6)
Male
(6)
Young Adult
(6)
Adolescent
(5)
Animals
(5)
Pharmacokinetics
(5)
Adult
(4)
Alemtuzumab
(4)
Child, Preschool
(4)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(4)
Hematopoietic Stem Cell Transplantation - Methods
(4)
Agriculture
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mathematical models to define growth patterns in indigenous horses of India

Phenotypic trend, breeding value and heritability of biometric traits in Marwari horses

Ameliorative Effect of Ascorbic Acid and Glutathione in Combating the Cryoinjuries During Cryopreservation of Exotic Jack Semen

Determination of genetic variability at αs1-casein gene in Indian dromedary

Genetic and demographic bottleneck analysis of Indian camel breeds by microsatellite markers

Freezability and Fertility Rates of Stallion Semen Supplemented With Trehalose in Lactose Extender

Camelpox: A brief review on its epidemiology, current status and challenges

Molecular characterization of Camelpox virus isolates from Bikaner, India: Evidence of its endemicity

A prospective pilot study of a novel alemtuzumab target concentration intervention strategy

CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study

Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults

Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation

Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series

Test‐dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non‐malignant disorders

Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study

Gene Therapy for Sickle Cell Anemia Using a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant Shows Promising Correction of the Disease Phenotype

Paperspray Ionization Mass Spectrometry as a Tool for Predicting Real-Time Optimized Dosing of the Chemotherapeutic Drug Melphalan

Daratumumab Is Safe and Effective for the Treatment of Refractory Autoimmunity in Children

Ruxolitinib for the Treatment of Chronic GVHD in Children and Young Adults

Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen

Pretransplant Absolute Lymphocyte Counts Impact the Pharmacokinetics of Alemtuzumab

An Intermediate Alemtuzumab Schedule Reduces the Incidence of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis

Alemtuzumab Precision Dosing in Allogeneic Hematopoietic Cell Transplantation

A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation

Intravenous Posaconazole is Safe and Effective in Pediatric HSCT Patients

Suchergebnisse filtern